Comparative registry of everolimus eluting stent and zotarolimus eluting stent in diffuse long coronary artery lesion (EXLONG registry); A multicenter, cohort observational study.

Trial Profile

Comparative registry of everolimus eluting stent and zotarolimus eluting stent in diffuse long coronary artery lesion (EXLONG registry); A multicenter, cohort observational study.

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Zotarolimus (Primary) ; Everolimus
  • Indications Coronary artery disease
  • Focus Therapeutic Use
  • Acronyms EXLONG
  • Most Recent Events

    • 24 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top